nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Ceftaroline fosamil—Renal failure—Mycophenolic acid—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.00514	0.00514	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Lisinopril—systemic scleroderma	0.00513	0.00513	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Leflunomide—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Leflunomide—systemic scleroderma	0.00505	0.00505	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Mometasone—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Leflunomide—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Ceftaroline fosamil—Anaemia—Captopril—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Ceftaroline fosamil—Constipation—Pentoxifylline—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Azathioprine—systemic scleroderma	0.00489	0.00489	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Ceftaroline fosamil—Renal failure—Lisinopril—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Ceftaroline fosamil—Palpitations—Captopril—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00476	0.00476	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Ceftaroline fosamil—Urticaria—Pentoxifylline—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Leflunomide—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Pentoxifylline—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Pentoxifylline—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Lisinopril—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Leflunomide—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00443	0.00443	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Captopril—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Lisinopril—systemic scleroderma	0.00439	0.00439	CcSEcCtD
Ceftaroline fosamil—Anaemia—Azathioprine—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Captopril—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Lisinopril—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Ceftaroline fosamil—Pain—Mometasone—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Ceftaroline fosamil—Infestation—Mycophenolate mofetil—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Ceftaroline fosamil—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Ceftaroline fosamil—Pruritus—Pentoxifylline—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Anaemia—Leflunomide—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Mometasone—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Lisinopril—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Mometasone—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mometasone—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Ceftaroline fosamil—Palpitations—Leflunomide—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Ceftaroline fosamil—Anaemia—Mycophenolic acid—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Ceftaroline fosamil—Dizziness—Pentoxifylline—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Ceftaroline fosamil—Erythema—Lisinopril—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Lisinopril—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Constipation—Captopril—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Ceftaroline fosamil—Palpitations—Mycophenolic acid—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Azathioprine—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Ceftaroline fosamil—Vomiting—Pentoxifylline—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Convulsion—Mycophenolic acid—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Ceftaroline fosamil—Rash—Pentoxifylline—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Pentoxifylline—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Ceftaroline fosamil—Headache—Pentoxifylline—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Captopril—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Leflunomide—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Ceftaroline fosamil—Pruritus—Mometasone—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Ceftaroline fosamil—Anaemia—Lisinopril—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Leflunomide—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Captopril—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Captopril—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Ceftaroline fosamil—Nausea—Pentoxifylline—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mometasone—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Prednisone—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Ceftaroline fosamil—Palpitations—Lisinopril—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mometasone—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Ceftaroline fosamil—Rash—Mometasone—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mometasone—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Headache—Mometasone—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Ceftaroline fosamil—Pruritus—Captopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Ceftaroline fosamil—Pain—Leflunomide—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Constipation—Leflunomide—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Prednisone—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Azathioprine—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Azathioprine—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Lisinopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Captopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Ceftaroline fosamil—Nausea—Mometasone—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Ceftaroline fosamil—Pain—Mycophenolic acid—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Constipation—Mycophenolic acid—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Prednisone—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Ceftaroline fosamil—Dizziness—Captopril—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Ceftaroline fosamil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Ceftaroline fosamil—Urticaria—Leflunomide—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Azathioprine—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Ceftaroline fosamil—Vomiting—Captopril—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Rash—Captopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Captopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Ceftaroline fosamil—Headache—Captopril—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Methotrexate—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Leflunomide—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Ceftaroline fosamil—Pain—Lisinopril—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Ceftaroline fosamil—Constipation—Lisinopril—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisone—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Azathioprine—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Ceftaroline fosamil—Nausea—Captopril—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Ceftaroline fosamil—Pruritus—Leflunomide—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Ceftaroline fosamil—Dizziness—Azathioprine—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Leflunomide—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Ceftaroline fosamil—Urticaria—Lisinopril—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Pruritus—Mycophenolic acid—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Ceftaroline fosamil—Vomiting—Azathioprine—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Rash—Azathioprine—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Azathioprine—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Headache—Azathioprine—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Ceftaroline fosamil—Dizziness—Leflunomide—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Prednisone—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Prednisone—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Ceftaroline fosamil—Pain—Mycophenolate mofetil—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Ceftaroline fosamil—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Ceftaroline fosamil—Vomiting—Leflunomide—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Ceftaroline fosamil—Dizziness—Mycophenolic acid—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Rash—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Nausea—Azathioprine—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Headache—Leflunomide—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Prednisone—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisone—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Ceftaroline fosamil—Pruritus—Lisinopril—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mycophenolic acid—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Ceftaroline fosamil—Rash—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Ceftaroline fosamil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Ceftaroline fosamil—Headache—Mycophenolic acid—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Nausea—Leflunomide—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Anaemia—Prednisone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Ceftaroline fosamil—Dizziness—Lisinopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Nausea—Mycophenolic acid—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Ceftaroline fosamil—Vomiting—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Rash—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisone—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Headache—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Nausea—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisone—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Prednisone—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Prednisone—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Rash—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Headache—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Ceftaroline fosamil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Constipation—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Ceftaroline fosamil—Pruritus—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Ceftaroline fosamil—Vomiting—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—systemic scleroderma	0.000985	0.000985	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—systemic scleroderma	0.000971	0.000971	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—systemic scleroderma	0.00092	0.00092	CcSEcCtD
